8374: Vegetable Consumption in Relation to Health

Sponsor
TNO (Other)
Overall Status
Completed
CT.gov ID
NCT00959790
Collaborator
Netherlands: Ministry of Health, Welfare and Sports (Other)
32
1
3
23
1.4

Study Details

Study Description

Brief Summary

Rationale: Consumption of vegetables is generally considered to be associated with several positive effects on health. Vegetables are a heterogeneous group of our diet which is rich in bio-actives. The vegetables contain a range of vitamins, minerals, dietary fibres and phytochemicals like potassium, flavonoids, carotenoids, and vitamin C. The recommended intake of vegetables by the Dutch Health Council is 200 grams daily (Health Council, 2006).

Health in this project is defined as the possibility of a subject to change and adapt easily in response to a certain challenge. Healthy subjects show resilience in different physiological processes related to oxidative stress, metabolic stress, neurological stress and inflammatory stress. The reaction/response to a challenge might be changed when subjects have consumed more or less vegetables and have an improved health status. The response might also differentiate between subjects differing in BMI (healthy weight versus overweight/obese). Supplementation of vegetables will be provided in two conditions: a low and a high daily intake (50 versus 200 grams daily). An intervention known to have positive effects on health is weight loss. This will be studied in relation to health (the reaction to the challenge test) as well.

A beneficial effect is present when 5% improvement of health markers is shown with vegetable supplementation, similar as is known from weight loss studies.

Objective: The primary objective of the present study is to set-up a methodology to investigate health based on the resilience to challenge. A secondary objective is the effectiveness of the challenge concept with a food intervention. The vegetable supplementation study is a first example to test the challenge concept. Therefore, vegetable consumption according to the recommendations of the Dutch Health Council of 200 grams of vegetables daily will be studied with an exercise challenge test, to investigate the beneficial 'health' effects.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Vegetables
  • Dietary Supplement: energy restriction
N/A

Detailed Description

Study design: The study is designed as a randomized, cross-over and parallel, open study.

Study population: The number of subjects participating in the study will be 32, healthy, lean and obese men, aged between 18-45 years.

Intervention: each intervention lasts four weeks:
  • High Vegetable treatment: consumption of 200 grams of vegetables daily;

  • Low Vegetable treatment: consumption of 50 grams of vegetables daily;

  • An energy restricted diet intervention with the habitual vegetable consumption.

Main study parameters/endpoints: A 'challenge test' will be used as a physical stress test to examine whether subjects show more or less resilience to the test. The reaction and recovery of the human system to the exercise test may be used as indicators of health status on different biological analyses (transcriptomics; metabolomics; rules based medicine pm). Different analyses to measure oxidative stress will be performed. Also standard health biomarkers will be determined to examine the intervention effects.

Study Design

Study Type:
Interventional
Actual Enrollment :
32 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Beneficial Effects of Vegetable Consumption and a Diet Intervention on Health in Lean and Obese Men.
Study Start Date :
Jan 1, 2009
Actual Primary Completion Date :
Dec 1, 2009
Actual Study Completion Date :
Dec 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Experimental: High vegetable dose

Consumption of 200 grams of vegetables daily, for four weeks.

Dietary Supplement: Vegetables
200 or 50 grams of vegetables daily for four weeks

Experimental: Low vegetable dose

Consumption of 50 grams of vegetables daily, for four weeks.

Dietary Supplement: Vegetables
200 or 50 grams of vegetables daily for four weeks

Active Comparator: Weight loss interventio

Consumption of - 1000 kcal daily, for four weeks to be used as a positive control for the vegetables interventions.

Dietary Supplement: energy restriction
Consume about 1000 kcal less daily, for four weeks, as a positive control to the vegetables interventions.

Outcome Measures

Primary Outcome Measures

  1. Investigate whether the maximal exercise performance test is a good concept for a challenge test, to examine 'health'. Health is defined as the ability to adapt in different circumstances. [after 4 weeks intervention]

Secondary Outcome Measures

  1. Compare outcomes on the exercise test after high or low vegetable consumption and after weight loss. Differences are expected between the lean and obese subjects. [after four weeks of intervention]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Healthy as assessed by the
  • health and lifestyle questionnaire, (P8374 F02; in Dutch)

  • physical examination

  • results of the pre-study laboratory tests

  1. Males aged between 18 and 45 years at Day 01 of the study

  2. Body Mass Index (BMI): for the lean : between 20 and 25 kg/m2; obese between 30 and 35 kg/m2

  3. Normal Dutch eating habits as assessed by P8374 F02

  4. Used to consume vegetables daily and liking vegetables (P8374 F02 and F06)

  5. Physically able to perform a maximal cycling exercise test

  6. Voluntary participation

  7. Having given written informed consent

  8. Willing to comply with the study procedures

  9. Appropriate veins for blood sampling according to TNO

  10. Willing to accept use of all nameless data, including publication, and the confidential use and storage of all data for at least 15 years

  11. Willing to accept the disclosure of the financial benefit of participation in the study to the authorities concerned.

Exclusion Criteria:
  1. Participation in any clinical trial including blood sampling and/or administration of substances up to 90 days before Day 01 of this study

  2. Participation in any non-invasive clinical trial up to 30 days before Day 01 of this study, including no blood sampling and/or oral, intravenous, or inhalatory administration of substances

  3. Having a history of medical or surgical events that may significantly affect the study outcome, including cardiovascular disease or hypertension and/or (food) allergy

  4. Using prescribed medication or taking pain killers on a regular basis (judged by the medical investigator) ;

  5. Smoking

  6. Exercise regularly and exceed the Dutch Standard of Healthy Physical Activity of 2.5 hours/week

  7. Alcohol consumption > 28 units/week

  8. Reported unexplained weight loss or gain of > 2 kg in the month prior to the pre-study screening

  9. Reported slimming or medically prescribed diet

  10. Recent blood donation (<1 month prior to the start of the study)

  11. Not willing to give up blood donation during the study

  12. Personnel of TNO Quality of Life, their partner and their first and second degree relatives

  13. Not having a general practitioner

  14. Not willing to accept information-transfer concerning participation in the study, or information regarding his health, like laboratory results, findings at anamnesis or physical examination and eventual adverse events to and from his general practitioner.

Contacts and Locations

Locations

Site City State Country Postal Code
1 TNO Quality of Life, Metabolic ward Zeist Utrecht Netherlands 3700 AJ

Sponsors and Collaborators

  • TNO
  • Netherlands: Ministry of Health, Welfare and Sports

Investigators

  • Principal Investigator: Wilrike Pasman, PhD, TNO
  • Study Director: Ineke Klöpping-Ketelaars, PhD, MD, TNO

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
W.J. Pasman, TNO, Zeist, The Netherlands, TNO
ClinicalTrials.gov Identifier:
NCT00959790
Other Study ID Numbers:
  • P8374
First Posted:
Aug 17, 2009
Last Update Posted:
Feb 28, 2012
Last Verified:
Feb 1, 2012
Keywords provided by W.J. Pasman, TNO, Zeist, The Netherlands, TNO
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 28, 2012